Kali Fluoratum Pellet
NDC Package 37662-3921-2
Package Information
Kali Fluoratum pellets is classified as a
- increased large intestinal motility - [pe] (physiologic effect)
- inhibition large intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- osmotic activity - [moa] (mechanism of action)
- osmotic laxative - [epc] (established pharmacologic class)
- potassium compounds - [cs]
- potassium salt - [epc] (established pharmacologic class)
Identification & Billing
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 37662 - Hahnemann Laboratories, Inc.
- 37662-3921 - Kali Fluoratum
- 37662-3921-2 - 1200 PELLET in 1 BOTTLE, GLASS
- 37662-3921 - Kali Fluoratum
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (37662-3921). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 37662-3921-2 identifies a specific commercial package of 1200 pellet in 1 bottle, glass of Kali Fluoratum, a human over the counter drug labeled by Hahnemann Laboratories, Inc.. This pellet is formulated for oral use and contains potassium fluoride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hahnemann Laboratories, Inc. on September 14, 2023. The current certification is valid through December 31, 2026.
How is this Hahnemann Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 37662392102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.